Načítá se...
Ras and exosome signaling
Ras gene (HRAS, NRAS, and KRAS) has been observed to be mutated and hyper-activated in a significant proportion of cancers. However, mutant Ras remains a challenging therapeutic target. Similarly, inhibition of targets upstream and downstream of Ras has shown limited clinical utility. There have bee...
Uloženo v:
| Vydáno v: | Semin Cancer Biol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6857536/ https://ncbi.nlm.nih.gov/pubmed/30769101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2019.02.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|